Virogen 1004-P96说明书
Virogen 1004-P96说明书
HEARTBREAKER-96
目录#1004-P96
摘要
两个96孔板的组织分解器
两个垂直定位的96孔板含有各种物质,在水平方向受到冲击,产生强大的破坏效果。它可以在冷藏室中使用或放在冰箱中,以保持样品在低温下消除噪音。由于快速中断过程,样品没有加热。
超过90%的研究和数千个临床实验室常规将组织均质化用于他们的研究。该过程中的关键步骤是用玻璃珠破坏组织。Heartbreaker-2为用户提供了优于现有治疗技术的*优势:
- 膜处理所有步骤的自动化。
- 处理六个膜,在两个测试线中分离,每个膜3个膜 – 两个独立工作的设备一次运行两个测试方案。
- 用自己的特异性抗体处理每个膜。六种不同的一级和六种不同的二级抗体可用于同时运行测试。
- 收集一抗用于重复使用。
- 从接触托盘和容器的试剂中自清洁设备。当测试周期结束时,机器已准备好进行新测试。
- 小所需的工作台空间(14“”“”x 14“”“”)。
- 一年保修。
用户的利益:
- 节省了工作台科学家的努力和时间。
- 通过在夜间进行蛋白质印迹加速研究过程。
- 标准化测试程序,使结果高度可靠。
定制机器可用于:
- 半自动加工塑料袋中的小尺寸膜。
- 单独操作的托盘一次根据六种不同的方案提供免疫印迹测试。
货号 |
品名 |
规格 |
价格 |
00211-V |
HHV-4 recombinant p18 antigen Region: 1-119aa |
100ug/vial |
4845 |
00212-V |
HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa |
100ug/vial |
4845 |
00213-V |
HHV-4 recombinant EA antigen. Region: 306-390aa |
100ug/vial |
4845 |
00167-V |
HDV Ag recombinant antigen |
100ug/vial |
4845 |
00214-V |
Tick-born encephalitis virus gE recombinant antigen |
100ug/vial |
4845 |
00206-V |
Toxoplasma gondii MIC 3 recombinant antigen |
100ug/vial |
4845 |
00207-V |
Toxoplasma gondii P24 (GRA1) recombinant antigen |
100ug/vial |
4845 |
00208-V |
Toxoplasma gondii P29 (GRA7) recombinant antigen |
100ug/vial |
4845 |
00209-V |
Toxoplasma gondii P30 (SAG1) recombinant antigen |
100ug/vial |
4845 |
00111-V |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
100ug/vial |
4845 |
00112-V |
HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
100ug/vial |
4845 |
00113-V |
HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
100ug/vial |
4845 |
00114-V |
HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
100ug/vial |
4845 |
00168-V |
HIV-1 p17/24/gp120-gp41 recombinant antigen. |
100ug/vial |
4845 |
00169-V |
HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
100ug/vial |
4845 |
00170-V |
HIV-1 gp41 recombinant antigen. |
100ug/vial |
4845 |
00171-V |
HIV-1 gp41 Long recombinant antigen. |
100ug/vial |
4845 |
00172-V |
HIV-1 p17-p24 recombinant antigen. |
100ug/vial |
4845 |
00173-V |
HIV-2 gp32 recombinant antigen. . |
100ug/vial |
4845 |
00174-V |
HIV-1 p24 recombinant antigen. |
100ug/vial |
4845 |
00175-V |
HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. |
100ug/vial |
4845 |
00176-V |
HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. |
100ug/vial |
4845 |
00177-V |
HIV 1 p24 core recombinant antigen. |
100ug/vial |
4845 |
00178-V |
HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. |
100ug/vial |
4845 |
00179-V |
HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. |
100ug/vial |
4845 |
00110-V |
HIV-1 tat recombinant antigen full length 15 kDa |
100ug/vial |
4845 |
00180-V |
HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. |
100ug/vial |
4845 |
00198-V |
HIV-1 reverse transcriptase recombinant antigen. |
100ug/vial |
4845 |
00199-V |
HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
100ug/vial |
4845 |
00115-V |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
100 ug/vial |
4845 |
00115-V-B |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
100 ug/vial |
4845 |
00115-V-F |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
100 ug/vial |
4845 |
00115-V-R |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
100 ug/vial |
4845 |
00116-V |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
100 ug/vial |
4845 |
00116-V-B |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
100 ug/vial |
4845 |
00116-V-F |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
100 ug/vial |
4845 |
00116-V-R |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
100 ug/vial |
4845 |
00117-V |
HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
100 ug/vial |
4845 |
00150-V |
HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
100 ug/vial |
4845 |
00151-V |
HCV core 24 antigen. |
100 ug/vial |
4845 |
00152-V |
HCV core recombinant antigen a.a.105-302 |
100 ug/vial |
4845 |
00153-V |
HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a |
100 ug/vial |
4845 |
00154-V |
HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 |
100 ug/vial |
4845 |
00155-V |
HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
100 ug/vial |
4845 |
00156-V |
HCV NS4 1916-1947aa recombinant antigen. |
100 ug/vial |
4845 |
00157-V |
HCV NS5 2061-2302aa recombinant antigen. |
100 ug/vial |
4845 |
00158-V |
HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
100 ug/vial |
4845 |
00120-V |
HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
100 ug/vial |
4845 |
00121-V |
HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
100 ug/vial |
4845 |
00122-V |
HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
100 ug/vial |
4845 |
00123-V |
HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
100 ug/vial |
4845 |
00124-V |
HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
100 ug/vial |
4845 |
00131-V |
HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
100 ug/vial |
4845 |
00132-V |
HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
100 ug/vial |
4845 |
00133-V |
HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
100 ug/vial |
4845 |
00141-V |
T. Pallidum recombinant antigen p15 (full length) |
100 ug/vial |
4845 |
00142-V |
T. Pallidum recombinant antigen p17 (full length) |
100 ug/vial |
4845 |
00143-V |
T. Pallidum recombinant antigen p45 (full length) |
100 ug/vial |
4845 |
00144-V |
T. Pallidum recombinant antigen TmpA (full length) |
100 ug/vial |
4845 |
00185-V |
CMV Pp65 (UL83) recombinant antigen , full length |
100 ug/vial |
4845 |
00188-V |
CMV Pp65 (UL83) recombinant antigen a.a. 297-510 |
100 ug/vial |
4845 |
00189-V |
CMV Pp52 (UL44) recombinant antigen a.a. 271-428 |
100 ug/vial |
4845 |
00187-V |
CMV gB-AD1 (UL55) recombinant antigen a.a. 549-645 |
100 ug/vial |
4845 |
00186-V |
CMV Pp150 recombinant antigen a.a. 426-606 |
100 ug/vial |
4845 |
00159-V |
HAV VP1-P2A recombinant antigen a.a. 722-830. |
100 ug/vial |
4845 |
00160-V |
HAV VP4-VP2 recombinant antigen a.a. 55-164. |
100 ug/vial |
4845 |
00161-V |
HAV P2C-P3A recombinant antigen a.a. 1492-1606. |
100 ug/vial |
4845 |
00162-V |
HAV P3C recombinant antigen a.a. 1643-1743. |
100 ug/vial |
4845 |
00163-V |
HAV VP3 recombinant antigen a.a. 304-415. |
100 ug/vial |
4845 |
00164-V |
HAV VP1-P2A recombinant antigen a.a. 669-782. |
100 ug/vial |
4845 |
00165-V |
HAV HAV P2C recombinant antigen a.a. 1121-1234. |
100 ug/vial |
4845 |
00166-V |
HAV P2C-P3A recombinant antigen a.a. 1392-1521. |
100 ug/vial |
4845 |
00181-V |
HSV-1 gD recombinant antigen a.a. 266-394. |
100 ug/vial |
4845 |
00182-V |
HSV-2 gD recombinant antigen a.a. 266-394. |
100 ug/vial |
4845 |
00183-V |
HSV-2 gD recombinant antigen a.a. 525-578. |
100 ug/vial |
4845 |
00184-V |
HSV-1 gD recombinant antigen a.a. 84-175. |
100 ug/vial |
4845 |
1131-V |
HSV-2 gB recombinant antigen |
100 ug/vial |
4845 |
00203-V |
HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. |
100 ug/vial |
4845 |
00204-V |
HLTV-I p24 core recombinant antigen. |
100 ug/vial |
4845 |
00205-V |
HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. |
100 ug/vial |
4845 |
00700-V |
HTLV-1 gp21 recombinant protein |
100 ug/vial |
4845 |
00701-V |
HTLV-1 gp46 recombinant protein |
100 ug/vial |
4845 |
00215-V |
Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. |
100 ug/vial |
4845 |
00216-V |
Rubella virus E2 recombinant antigen a.a. 31-105. |
100 ug/vial |
4845 |
00217-V |
Rubella virus capsid (C) recombinant antigen a.a. 1-123. |
100 ug/vial |
4845 |
00191-V |
SARS-Associated Coronavirus E recombinant antigen a.a. 1-76. |
100 ug/vial |
4845 |
00192-V |
SARS-Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1-49. |
100 ug/vial |
4845 |
00193-V |
SARS-Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340-390. |
100 ug/vial |
4845 |
00194-V |
SARS-Associated Coronavirus M recombinant antigen a.a. 182-216. |
100 ug/vial |
4845 |
00195-V |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. |
100 ug/vial |
4845 |
00196-V |
SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. |
100 ug/vial |
4845 |
Virogen中国代理,Virogen上海代理,Virogen北京代理,Virogen广东代理,Virogen江苏代理Virogen湖北代理,Virogen天津代理,Virogen黑龙江代理,Virogen湖南代理Virogen内蒙古代理,Virogen吉林代理,Virogen福建代理,Virogen江苏代理,Virogen浙江代理,Virogen四川代理,Virogen代理,
上海金畔生物科技有限公司是实验试剂一站式采购服务商
1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。
2:产品种类齐全,经营超过700多品牌,基本涵盖所有生物实验试剂耗材。
3:提供加急服务,货品一般1-2周到货。
4:富有竞争良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等知药企。
6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。
7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知*批发,欢迎合作。